Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [ 3 H]eletriptan binding at human 5-HT 1B and 5-HT 1D receptors

By Napier C.   Stewart M.   Melrose H.   Hopkins B.   McHarg A.   Wallis R.  

European Journal of Pharmacology, Vol. 368, Iss. 2, 1999-03 ,pp. : 259-268

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT 1A receptor

By Jordan S.   Koprivica V.   Chen R.   Tottori K.   Kikuchi T.   Altar C.A.  

European Journal of Pharmacology, Vol. 441, Iss. 3, 2002-04 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D.   Fleishaker Joseph C.  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

Rizatriptan: a new 5-HT_1B/1D receptor agonist for the treatment of migraine

By Dahlof C.   Lines C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 671-685

Informa Healthcare

Access to resources Recommend Favorite